These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17060667)

  • 1. (R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con].
    Ameredes BT; Calhoun WJ
    Am J Respir Crit Care Med; 2006 Nov; 174(9):965-9; discussion 972-4. PubMed ID: 17060667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with (R)-albuterol has no advantage over racemic albuterol.
    Barnes PJ
    Am J Respir Crit Care Med; 2006 Nov; 174(9):969-72; discussion 972-4. PubMed ID: 17060668
    [No Abstract]   [Full Text] [Related]  

  • 3. Levalbuterol and racemic albuterol: are there therapeutic differences?
    Ahrens R; Weinberger M
    J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
    [No Abstract]   [Full Text] [Related]  

  • 4. Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?
    Asmus MJ; Hendeles L
    Pharmacotherapy; 2000 Feb; 20(2):123-9. PubMed ID: 10678290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma pathophysiology and evidence-based treatment of severe exacerbations.
    Schreck DM
    Am J Health Syst Pharm; 2006 May; 63(10 Suppl 3):S5-13. PubMed ID: 16679429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with levalbuterol.
    Nelson HS
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levalbuterol versus albuterol.
    Ameredes BT; Calhoun WJ
    Curr Allergy Asthma Rep; 2009 Sep; 9(5):401-9. PubMed ID: 19671384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
    Schreck DM; Babin S
    Am J Emerg Med; 2005 Nov; 23(7):842-7. PubMed ID: 16291438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost effectiveness of levalbuterol versus racemic albuterol.
    Quinn C
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S153-7. PubMed ID: 15354680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levalbuterol hydrochloride.
    Slattery D; Wong SW; Colin AA
    Pediatr Pulmonol; 2002 Feb; 33(2):151-7. PubMed ID: 11802253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salamol--was it worth it?
    Beckert L; Edwards A
    N Z Med J; 2007 Dec; 120(1267):U2875. PubMed ID: 18157201
    [No Abstract]   [Full Text] [Related]  

  • 12. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
    Handley D
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
    Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
    J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol: a long-acting beta 2-agonist for asthma.
    Nurse Pract; 1994 Jul; 19(7):9-10. PubMed ID: 7936460
    [No Abstract]   [Full Text] [Related]  

  • 15. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma.
    Hamilos DL; D'Urzo A; Levy RJ; Marcus M; Tripp K; Parsey M; Baumgartner RA; McVicar WK
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):540-8. PubMed ID: 18219836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmeterol for the treatment of asthma.
    Weinberger M
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Question from the clinician: levalbuterol in managing pediatric asthma.
    Abbott MB; Levin RH; Miller JA
    Pediatr Rev; 2002 Nov; 23(11):401-3. PubMed ID: 12415020
    [No Abstract]   [Full Text] [Related]  

  • 20. Paradoxical response to levalbuterol.
    Broski SE; Amundson DE
    J Am Osteopath Assoc; 2008 Apr; 108(4):211-3. PubMed ID: 18443029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.